Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan

BACKGROUND: Sacubitril/valsartan is approved for the treatment of chronic heart failure with reduced left ventricular ejection fraction of ≤40% to decrease mortality and morbidity. Nasal pruritus is not a recognized adverse effect in the product information. In this case series, we encountered three...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Jaclyn, Rheault, Haunnah, Wong, Yee Weng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717058/
https://www.ncbi.nlm.nih.gov/pubmed/34993412
http://dx.doi.org/10.1093/ehjcr/ytab506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717058/
https://www.ncbi.nlm.nih.gov/pubmed/34993412
http://dx.doi.org/10.1093/ehjcr/ytab506

Ejemplares similares